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Abstract
The appropriate exposure metrics for characterizing manganese (Mn) exposure associated with 
neurobehavioral effects have not been established. Blood levels of Mn (B-Mn) provide a 
potentially important intermediate marker of Mn airborne exposures. Using data from a study of a 
population of silicon- and ferro-manganese alloy production workers employed between 1973 and 
1991, B-Mn levels were modeled in relation to prior Mn exposure using detailed work histories 
and estimated respirable Mn concentrations from air-sampling records. Despite wide variation in 
exposure levels estimated for individual jobs, duration of employment (exposure) was itself a 
strong predictor of B-Mn levels and strongest when an 80-day half-life was applied to 
contributions over time (t = 6.95, 7.44, respectively; p < 10 −5). Partitioning exposure 
concentrations based on process origin into two categories: (1) “large” respirable particulate (Mn-
LRP) derived mainly from mechanically generated dust, and (2) “small” respirable particulate 
(Mn-SRP) primarily electric furnace condensation fume, revealed that B-Mn levels largely track 
the small, fume exposures. With a half-life of 65 days applied in a model with cumulative 
exposure terms for both Mn-LRP (t = −0.16, p = 0.87) and Mn-SRP (t = 6.45, p < 10 −5), the 
contribution of the large-size fraction contribution was negligible. Constructing metrics based on 
the square root of SRP exposure concentrations produced a better model fit (t = 7.87 vs. 7.44, R2 = 
0.2333 vs. 0.2157). In a model containing both duration (t = 0.79, p = 0.43) and (square root) fume 
(t = 2.47, p = 0.01) metrics, the duration term was a weak contributor. Furnace-derived, small 
respirable Mn particulate appears to be the primary contributor to B-Mn levels, with a dose-rate 
dependence in a population chronically exposed to Mn, with air-concentrations declining in recent 
years. These observations may reflect the presence of homeostatic control of Mn levels in the 
blood and other body tissues and be useful in assessing Mn exposures for evaluating neurotoxic 
effects.
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1. Introduction
It is well known that occupational exposure to manganese (Mn) is associated with 
neuropsychological and neurological deficits and disorders, on a continuum of severity, 
depending on external exposure dose (for review see: Mergler and Baldwin, 1997; Mergler 
et al., 1999; Zoni et al., 2007; Guillarte, 2010). Despite an extensive literature on this 
subject, results are inconsistent on the relations between exposure parameters and internal 
biomarkers of Mn (Smith et al., 2007). In general, Mn-exposed workers present higher blood 
Mn (B-Mn) compared to non-exposed referents (Mergler and Baldwin, 1997; Zheng et al., 
2011), but few studies have observed dose-relations.
In their pioneering study of workers exposed to manganese oxides, Roels et al. (1987) 
reported that individual B-Mn concentration did not correlate with current exposures to Mn 
in total dust or to exposure duration; however, B-Mn was correlated to the chief foreman’s 
ranked estimation of integrated exposure for 11 departments. In an Italian study of ferroalloy 
workers, who were tested during a period of suspended production, B-Mn was positively 
correlated with an estimate of cumulative exposure to Mn in total dust (Lucchini et al., 
1995). This workforce did not have Mn exposures 1–42 days prior to assessment. The 
authors hypothesize that B-Mn might reflect the rate at which excess manganese, 
accumulated over time, was being excreted. Interestingly, in a later follow-up of these same 
workers but now with current Mn exposures, there was a significant positive correlation 
between B-Mn and airborne Mn in total dust, but no association with estimated cumulative 
exposure (Lucchini et al., 1999). In a Norwegian study of Mn alloy production workers, 
where both inhalable and respirable Mn were measured, B-Mn showed a weak association 
with the respirable fraction, but no association with inhalable (Ellingsen et al., 2003). A 
South African study of smelter workers showed a positive correlation between B-Mn and 
Mn intensity in current job, and increasing B-Mn with time spent in that particular job, but 
not with overall employment duration (Myers et al., 2003). In a study of bridge welders 
working in confined spaces for 2 years or less, B-Mn was predicted by both duration and 
cumulative exposure but prediction improved when a half-life of 150 days was applied to 
Mn exposure levels (Park et al., 2009).
Systemic uptake of Mn occurs largely via the pulmonary route because excess Mn absorbed 
from the GI tract is efficiently eliminated (Andersen et al., 1999). Larger inhaled particles 
(>10.0 µm) are generally transported to the GI tract. Uptake of very small (nano-sized) 
particles containing Mn via the olfactory nerve has been proposed (Elder et al., 2006; 
Sunderman, 2001). The relative potency of airborne Mn in the respirable size range, when 
present as larger (dust) or smaller (fume) particulate, remains to be determined.
Manganese alloy production workers are exposed to a wide range of particulate size. In 
1994, Mergler et al. (1994) published a matched pair study of neurobehavioral outcomes, 
comparing Mn alloy workers to a referent group of non-occupationally exposed workers 
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from the same geographic region. The plant in Quebec, Canada, was in operation from 1973 
to 1991 and, at the time of the study, the geometric mean for Mn in total dust was 0.23 
mg/m3 and in the respirable fraction was 0.04 mg/m3 (Mergler et al., 1994). Baldwin et al. 
(2008) developed exposure histories for the workers from this plant for use in follow-up 
studies (Bouchard et al., 2007a,b, 2008).
The initial goal of the current investigation was to use this extensive database to examine the 
relations between B-Mn and history of respirable Mn exposure, with a view to determining 
the optimum exposure metric for predicting B-Mn. Since preliminary analyses indicated that 
the duration of exposure (with half-life weighting) was itself an important predictor of B-Mn 
levels, we decided to distinguish respirable airborne Mn in dust of mechanical origin, 
thought to be relatively large respirable particulate (Mn-LRP), from condensation fume 
assumed to be relatively small respirable particulate (Mn-SRP). The latter was assumed to 
have slower sedimentation rates and be more uniformly distributed across the alloy facility 
due to its much smaller particle size. In the absence of detailed particle-size information, we 
assume that Mn-LRP exposures were generally >1.0 µm in mass median aerodynamic 
diameter and Mn-SRP exposures <1.0 µm diameter. The present study investigates the 
separate contributions of Mn-LRP and Mn-SRP to B-Mn concentrations in these Mn alloy 
production workers.
2. Methods
2.1. Database
The original study recruited 115 workers from a ferro- and silico-Mn alloy production plant 
(95% of the total workforce) and 145 non-exposed workers from the same community as 
referents (Mergler et al., 1994). All production was in batches using a single, sealed 
submerged electric arc furnace. The retrospective Mn exposure assessment is published 
elsewhere (Baldwin et al., 2008). It was based on work history and environmental sampling. 
Work history consisted of the sequence of job group assignments from payroll records for 
each worker with associated dates. Individual exposure profiles of many workers were 
complex due to frequent job rotations with differing exposure levels. Some workers held 
more than 20 job assignments. During plant operations from 1973 to 1991, there was 
relatively little work-force turnover. At the time of the neurobehavioral assessment, during 
the fourth quarter of 1990, blood samples were taken prior to exposure on the last day of the 
worker’s shift. Methods of blood sampling and Mn determinations by flameless atomic 
absorption spectrophotometry are described in Mergler et al. (1994).
Exposure measurements included: (a) results from a 1990– 1991 industrial hygiene survey, 
which provided full-shift personal and area sampling data for particulate, not otherwise 
specified (PNOS) (i.e., total gravimetric dust) and for Mn content in the dust, together with 
full-shift area samples of respirable dust and its Mn content; (b) historical short-term 
personal and area total dust samples from 1978 to 1984; and (c) three surveys of the furnace 
team between 1987 and 1989, which contained personal air sampling data for total dust and 
Mn content (Baldwin et al., 2008). The compilation of historical exposure information, 
additional air sampling in 1990–1991, and the construction of retrospective exposure 
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estimates of respirable Mn were performed by professional industrial hygienists under the 
supervision of one of the study investigators (M. Baldwin, CIH, ROH (Canada)).
In the exposure reconstruction (Baldwin et al., 2008), which is briefly summarized here, job 
groups were defined. Estimates for total manganese were based on averages within fourteen 
discrete time periods, and changes between periods were derived from documented work 
practice and/or ventilation changes, or plant closures. Because there were no data earlier 
than 1978, and because no major modifications (other than plant closures) had taken place 
between 1973 and 1978, the assumption was made that conditions in 1978 were 
representative of those prior to that time. In the absence of personal respirable sampling 
data, estimates of respirable manganese for the job groups were based on the paired area 
sampling data collected in April–March of 1991.
Most jobs sampled in 1991 were located in the four main areas of the plant: the raw 
materials yard, the furnace floor, the crushing/end product handling area and the 
maintenance building. The ratio of the geometric mean (GM) of respirable Mn to total Mn 
for a given area was applied to all total Mn estimates over time for jobs within that area. 
This assumes that the ratio of respirable to total Mn was characteristic of a given area and 
stable over time and that the area ratio was applicable to personal exposure for job groups 
located in that area. For those who worked across the plant, the overall ratio for the plant 
was used. For the few jobs in the sinter plant, which closed in 1988, 5% of total Mn was 
stipulated to be respirable, as the very heavy dust levels in this area were mechanically 
derived from slag and coke. Those exposures would have made a small contribution to blood 
levels 3 years later.
2.2. Construction of dust and fume exposure metrics
To investigate the separate contributions of Mn-LRP and Mn-SRP to Mn in total respirable 
particulate (Mn-TRP), corresponding exposure metrics were constructed (Table 1). Using 
the job and process descriptions observed by Baldwin et al. (2008), the general exposure 
status of all jobs was classified in four groups:
1. Primarily fume: In these jobs, the men worked in close proximity to furnace 
operations on the furnace floor, with exposure to fumes from the hot metal pours 
and no major mechanical dust source. The estimate for Mn-TRP is based on the 
data reported for the furnace team, was entirely allocated to Mn-SRP exposure; 
Mn-LRP was set to zero.
2. Both dust and fume: The jobs assigned to this category had substantial exposure to 
both mechanical dust and fume. Included were those in the product crushing area, 
which was in close proximity to the furnace bays, and maintenance workers, who 
worked in the furnace area. They were assigned the Mn-SRP of the furnace team 
and the Mn-LRP value was set as the difference between Mn-TRP for the job and 
the assigned Mn-SRP value. If the assigned Mn-SRP value was greater than half of 
the Mn-TRP for a job, then both Mn-LRP and Mn-SRP were set as half the Mn-
TRP.
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3. Primarily dust: These jobs involved mechanical crushing and handling more distant 
from furnace fume generation. They mainly included jobs in the raw materials yard 
and the sinter operation. They were assigned the intermediate Mn-SRP level of the 
furnace loader operator, which was lower than the furnace team; Mn-LRP was 
calculated as above.
4. Ambient: These jobs were distant from the furnace and Mn crushing operations, e.g. 
in the maintenance workshop, or in the silicon plant, and the Mn-SRP 
concentration was set to the Mn-TRP for the job and Mn-LRP as set to zero.
For each job, in each exposure period, the resulting estimates for Mn-LRP and Mn-SRP 
concentrations summed to the estimate for Mn-TRP derived from the air sampling data. The 
choices made in this classification were based on observation of plant operations and 
physical configuration by the industrial hygienist-investigator, as well as the area air 
sampling results. With the exception of a revised adjustment in some levels accounting for 
the closure of the sintering operations, a major dust contributor, these specifications were 
defined prior to detailed analyses for predicting B-Mn, but after the observation that 
exposure duration by itself was a major predictor of B-Mn.
2.3. Exposure metrics
To model blood manganese levels, cumulative respirable Mn exposure was calculated in the 
usual manner as a time-weighted sum of job assignment exposures up until the date of blood 
collection. Because excess Mn is cleared from the body, Mn exposure burdens (BMn) were 
calculated, as follows:
where X(i) is the estimated Mn-TRP (Mn-LRP or Mn-SRP) at time, i; t1 is the index of time 
periods corresponding to the first exposure, t2 corresponds to the last exposure and T½ is the 
half-life or time-constant for the declining contribution of an Mn exposure to future blood 
levels. Time, i, in this calculation, was partitioned in 10-day units. With half-life 
approaching ∞, BMn becomes the usual cumulative exposure. The range of half-lives 
analyzed was based on physiological plausibility, recognizing that complex clearance 
patterns from diverse tissues are present and being summarized with a single constant. When 
applied to Mn exposures this time-weighting was also applied to duration of Mn exposure. 
In order to assess dose-rate effects, where the air concentration at a point in time does not 
contribute proportionately to the cumulative exposure or burden metrics, the metrics were 
also calculated based on the square root and square of the estimated air Mn concentrations.
2.4. Statistical analysis
Blood Mn was modeled in relation to past Mn exposure, age and education. Multiple linear 
regression models were fit using proc REG in SAS (SAS Institute, 2011). Regression 
diagnostics were examined. Age centered at 40 yr, and education centered at 12 yr, together 
with their squares, were included in models whether or not statistically significant, to adjust 
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for possible physiological effects (age) and possible exposure misclassification related to 
skill status (education). These effects were very small. Different exposure metrics were 
compared based on model R2 and exposure-term associated t-statistics. The model form was 
as follows:
where metX is an exposure metric: duration, cumX, etc.
3. Results
Study population: Following exclusion for missing data on B-Mn, education or age, 104 
alloy production workers and 131 non-exposed workers from the surrounding region were 
used in the models. The average age of the workers and the referents was 44.2 ± 5.8 and 
43.1 ± 7.2 years, respectively, and average years of education was 10.6 ± 2.1 and 10.8 ± 2.6, 
respectively. The mean employment duration of the Mn alloy workers was 14.4 yr ± 1.8, 
ranging from 7.4 to 16.1 yr.
3.1. Exposure matrix
Based on the process described in Table 1, Tables 2 and 3 present the mean Mn-LRP and the 
Mn-SRP, respectively, for the different job groupings over selected periods. For the most 
part, respirable Mn concentrations in dust and fume declined after 1987. Mn-LRP 
concentrations were higher than Mn-SRP in the early years, but not after closing of sinter 
operations in 1988. In the study plant population at the time of the survey, the mean time-
weighted average exposure of each worker was for Mn-LRP: 0.065 mg/m3, for Mn-SRP: 
0.082 mg/m3 and for Mn-TRP: 0.148 mg/m3. The mean cumulative exposures were Mn-
LRP: 0.918 mg/m3-yr; Mn-SRP: 1.175 mg/m3-yr; Mn-TRP: 2.093 mg/m3-yr.
3.2. Models of blood manganese levels
In analyses controlling for age and education, workers ever employed in the Mn plant 
compared to the referent group had a highly statistically significant elevation of manganese 
in blood (B-Mn) (t = 7.14, R2 = 0.2032, p < 10−10) (Table 4). The model-predicted value of 
B-Mn in the comparison group was 7.2 µg/L and in the exposed group was 10.64 µg/L (data 
not shown). Duration of Mn exposure was a comparable predictor of B-Mn but with slightly 
inferior fit (R2 = 0.1956) (Table 4). The usual Mn cumulative exposure metrics, for Mn-
TRP, Mn-LRP and Mn-SRP, were weaker predictors of B-Mn than duration, particularly 
Mn-LRP (Table 4).
Table 5 presents a series of models for B-Mn using different measures of exposure at 
increasing Mn half-life. Exposure metrics in the form of duration with a half-life of 80 days 
or burdens with a half-life in the range 60–65 days better predicted B-Mn (Table 5) than 
metrics without an applied half-life. Mn-SRP burden (half-life = 60 days) was the best 
predictor (t = 7.46, R2 = 0.216, model 12) but only slightly better than duration (t = 7.41, R2 
=0.215, model 9) and Mn-LRP was the poorest predictor (t = 3.40, R2 = 0.072, model 11). 
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Terms for education and age were statistically insignificant except for a suggestion of a 
negative effect for the linear education term.
Burdens were also calculated based on the square root or square transformation of Mn 
exposure metrics to address possible dose-rate effects. The burden using square root of Mn-
SRP exposure with a half-life 65 days produced a model fitting somewhat better (t = 7.87, 
R2 = 0.233) than with duration or untransformed Mn-SRP (Table 5; models 13 and 16). Fig. 
1 displays the observed and predicted values of B-Mn with square root of Mn-SRP 
exposure; the comparison population (exposure = 0) is included. Mn-TRP (model 14) and 
Mn-LRP (model 15) also improved when based on the square root of Mn concentration. 
Burdens based on the square of exposure intensity were poor predictors of B-Mn (data not 
shown). Short half-lives of 1–4 days, corresponding to the known rapid elimination of recent 
Mn exposure, produced poor fitting models, and when included along with the best predictor 
(square root of cumulative Mn fume, 65 day half-life) did not at all improve model fit (data 
not shown).
Table 6 presents models of B-Mn with competing Mn exposure metrics, using a half-life of 
65-days. Models with the best Mn Mn-SRP metric, together with duration or Mn-LRP 
terms, demonstrate the dominance of Mn-SRP in predicting blood Mn levels. Using both 
Mn-LRP and Mn-SRP, with no dose-rate effect (model 4), the Mn-LRP contribution is 
insignificant (t = 0.16) and negative; with duration and Mn-SRP (model 5) both terms are 
important predictors of comparable fit (t = 2.45, 2.53, respectively). Allowing for the dose-
rate effect using square root of exposure intensity in calculating burden, the unimportance of 
Mn-LRP was again observed (model 7) and now Mn-SRP (t = 2.47) was a much better 
predictor when competing with duration (t = 0.79) (model 8). In the models presented in 
Table 6, regression diagnostics revealed no important departures in distributions of residuals 
from model assumptions.
4. Discussion
4.1. Fume as the dominant exposure
The observation that duration of Mn exposure (with a half-life applied) was comparable to 
the better burden metrics in predicting B-Mn suggests that the relevant exposure is widely 
and somewhat uniformly dispersed spatially and over time. In this ferro- and silico-alloy 
facility, this finding would point to Mn condensation fume from the furnace as the most 
likely source. The observed superior prediction with the derived Mn-SRP metric and the 
much inferior prediction with the Mn-LRP metric supports this conclusion. Manganese fume 
is known to form aggregates of primary particles fused together and agglomerates which are 
clusters of primary particles that adhere via electrostatic forces (Jenkins et al., 2005). The 
clusters are often in the form of strings, and the spatial dispersion of the small particles 
within the agglomerates would result in lower sedimentation rates, more like those of the 
small spherical particles comprising the agglomerates.
Alternatively, the uptake and tissue distribution of Mn from the lungs may be non-linear, 
increasing much less than proportionally with increasing air concentrations. This would 
occur if homeostatic metabolic regulation was limiting blood and tissue level Mn 
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excursions. Observing a dose-rate effect with square root of Mn-SRP supports this 
hypothesis, as does the reduction in the joint contribution of duration when the square root is 
applied in calculating Mn-SRP for predicting B-Mn (Table 6; models 5 vs. 8).
The observed optimum half-life of about 65 days for predicting Mn blood levels is 
consistent with reported brain and bone clearance half-life (“half-lives greater than 50 days,” 
as summarized in Andersen et al., 1999). However, half-life in this context is complicated, 
reflecting different tissue-specific clearance rates including the release of Mn irreversibly 
bound to red blood cells, which live 100–120 days (H. Clewell, September 24, 2013, private 
correspondence).
Extensive investigations of animal and human data and the development of physiologically-
based pharmacokinetic (PBPK) models have revealed a complex metabolic regulation of Mn 
tissue levels and demonstrate dose-dependent clearance rates that would tend to moderate 
tissue level excursions even with highly variable inhalation exposures (Andersen et al., 
2010; Schroeter et al., 2011). Whether this PBPK model would imply piece-wise linear 
regions in the relationship between air concentrations and brain-tissue concentrations, with a 
smaller slope in the region of metabolic control, cannot be discerned from Schroeter et al. 
(2011). At higher exposures the relationship is concave downward due to biliary induction 
(H. Clewell, September 24, 2013, private correspondence). Under the exposure conditions of 
the current study (air concentrations generally <0.2 mg/m3 small respirable Mn particulate), 
duration of exposure over a broad range of exposure levels (0.01–0.4 mg/m3, with a half-life 
applied), appears to be an efficacious exposure metric for predicting B-Mn, although not as 
good as the small respirable particulate (square root) metric.
Misclassification in the Mn-SRP metric would tend to diminish its relative predictive ability 
compared to duration, a precisely known entity. The superior prediction with calculation of 
burdens using square root of fume exposure intensity could represent a reduction in 
misclassification if the errors were greater at extreme values of the exposure metric.
Several aspects of Mn exposure as examined here may be important in explaining 
inconsistencies across studies in predicting B-Mn levels. Differences in the time course of 
exposure may be partially accommodated with application of a half-life weighting even 
though it represents a crude physiological approximation. A dose-rate effect, possibly 
related to homeostasis, and attention to the size, structure and solubility of Mn-containing 
respirable particulates could also bring some coherence to conflicting observations. The 
LRP and SRP exposures may have important differences not only on particle size, but also 
on process-related features such as surface oxide composition and the ratio of surface area to 
mass that could affect solubility and peak levels of Mn in blood under conditions of time-
variable exposure. Application of metrics addressing these issues in other populations is 
needed for validation. This study does not imply that current B-Mn is itself an appropriate 
predictor of health effects.
The different associations between B-Mn and respirable Mn in dust and fumes for this Mn 
alloy facility has implications for other populations. It suggests that welders may receive 
higher biologically effective doses than workers exposed to similar concentrations of 
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respirable dusts consisting of larger non-agglomerated particles and that the size distribution 
of sub-micron dusts may be important (Jenkins et al., 2005; Zimmer and Biswas, 2001). 
Therefore, in investigating neurobehavioral effects in Mn-exposed worker populations, 
exposure metrics attentive to sub-micron size distribution would be appropriate. Although 
representing probably very different physiological processes, the uptake of lead (Pb) into the 
blood has also been observed to be higher than expected when present as a furnace-
generated fume compared to larger-particulate dusts generated mechanically (Froines et al., 
1986) or when large particles are less prevalent (Hodgkins et al., 1992).
4.2. Limitations of study
The derivation of Mn dust and fume levels depended on a reconstruction of respirable Mn 
levels from historical total dust measurements to which were applied estimates of the 
respirable proportion and Mn composition across job groups. These estimates were based 
entirely on surveys performed in 1991 and assumed that the ratio of respirable to total Mn 
was characteristic of a given area and stable over time and that the area ratio was applicable 
to personal exposure for job groups located in that area (Baldwin et al., 2008). Given the 
available data, as in any retrospective exposure assessment, this procedure undoubtedly 
entailed considerable exposure misclassification. Assumptions made in partitioning the dust 
and fume components could have introduced further misclassification. As a consequence of 
the rapid decline over time of the contribution of a Mn exposure to future B-Mn, the 
exposures determining model fit were largely recent ones – within prior 2 years. In this 
study these later exposures were more dominated by fume than earlier due to the closing of 
the sinter operation, although in the product crushing area, dust levels remained quite 
uniform over time. The striking difference in predictive ability between Mn-SRP and Mn-
LRP is unlikely to have resulted largely from misclassification, a condition that typically 
degrades prediction rather than strengthening it.
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Fig. 1. 
Blood manganese: actual vs. predicted by small resp. particulate (cum. sq. root) for both 
alloy workers and community worker controls corresponding to Table 5, model 16 and 
Table 6, model 6.
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Table 1
Job group exposure assignment procedure.
Job group General exposure
status
% Resp Fume-analog job group Procedure
Furnace team Primarily Fume 13 Assign fume concentration based on estimated 
respirable
Furnace, laborer 13 Mn for Job.
Furnace loader opr 13 Assign dust concentration=0
Furnace, sampler 13
Instrument. tech 13
Furnace, gas system 13
Furnace, Kress opr 13
Control rm opr Dust and Fume 19 Furnace team Assign fume concentration based on estimated 
respirable
Product crushing, other 12 Furnace team Mn in Fume-analog Job.
Electricians 12 Furnace team Derive dust concentration as difference 
between estimated
respirable Mn for Job minus assigned fume 
concentration.
If assigned fume conc. >(estimated respirable 
Mn for Job)/2,
then set both dust and fume=(estimated 
respirable
Mn for Job)/2
Welders 12 Furnace team
Fitters 12 Furnace team
Product crushing, hopper 12 Furnace team
Equip opr, raw matl Primarily Dust 22 Furnace loader opr
Yard laborer 22 Furnace loader opr
Janitor 19 General equip. maint., 
head
Sinter plant, opr 5 Furnace loader opr
Sinter plant, laborer, asst opr 5 Furnace loader opr
Sinter plant, foreman 5 Furnace loader opr
Product crushing, brakeman 12 Furnace loader opr
Maintenance, dust collector 11 Furnace loader opr
Yard, truck/machine 11 Furnace loader opr
Maintenance shop Ambient 21 Assign fume concentration based on estimated 
respirable
Silicon plant 10 Mn for Job.
General equip. maint., head 21 Assign dust concentration=0
Maintenance, supvr 21
Fume analog: similar job group with only fume exposure; used to assign fume level to jobs with dust exposure.
Neurotoxicology. Author manuscript; available in PMC 2015 August 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Park et al. Page 13
Ta
bl
e 
2
Es
tim
at
ed
 la
rg
e 
re
sp
ira
bl
e 
pa
rti
cu
la
te
 e
xp
os
ur
e:
 m
g/
m
3  
as
 r
es
pi
ra
bl
e 
M
n 
(M
n-L
RP
) i
n s
ele
cte
d t
im
e p
eri
od
s
Pe
ri
od
1
3
5
6
8
9
10
11
14
M
id
-y
ea
r
19
74
19
77
19
79
19
82
19
85
19
87
19
88
19
89
19
90
Pr
im
ar
ily
 fu
m
e
 
 
 
 
Fu
rn
ac
e 
te
am
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Fu
rn
ac
e,
 la
bo
re
r
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Fu
rn
ac
e 
lo
ad
er
 o
pr
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Fu
rn
ac
e,
 sa
m
pl
er
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
In
st
ru
m
en
t. 
te
ch
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Fu
rn
ac
e,
 g
as
 sy
ste
m
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Fu
rn
ac
e,
 K
re
ss
 o
pr
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
D
us
t a
nd
 fu
m
e
 
 
 
 
Co
nt
ro
l r
m
 o
pr
0.
01
1
0.
01
1
0.
00
6
0.
01
1
0.
03
7
0.
00
8
0.
00
8
0.
00
6
0.
00
3
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 o
th
er
0.
08
7
0.
08
7
0.
09
2
0.
08
7
0.
05
5
0.
05
5
0.
05
5
0.
05
5
0.
02
3
 
 
 
 
El
ec
tri
ci
an
s
0.
38
6
0.
38
6
0.
47
0
0.
38
6
0.
27
6
0.
43
3
0.
14
8
0.
09
9
0.
04
4
 
 
 
 
W
el
de
rs
0.
08
6
0.
08
6
0.
09
0
0.
08
6
0.
08
6
0.
08
6
0.
04
0
0.
02
6
0.
01
2
 
 
 
 
Fi
tte
rs
0.
26
9
0.
26
9
0.
35
3
0.
26
9
0.
21
7
0.
31
6
0.
10
5
0.
07
0
0.
03
1
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 h
op
pe
r
0.
16
9
0.
16
9
0.
25
2
0.
16
9
0.
16
7
0.
21
5
0.
21
5
0.
25
4
0.
00
0
Pr
im
ar
ily
 d
us
t
 
 
 
 
Eq
ui
p 
op
r, 
ra
w
 m
at
l
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
00
3
0.
00
3
0.
00
3
 
 
 
 
Y
ar
d 
la
bo
re
r
0.
03
1
0.
03
1
0.
03
1
0.
03
1
0.
03
1
0.
03
2
0.
00
4
0.
00
4
0.
00
4
 
 
 
 
Ja
ni
to
r
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
 
 
 
 
Si
nt
er
 p
la
nt
, o
pr
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Si
nt
er
 p
la
nt
, l
ab
or
er
, a
ss
t o
pr
0.
45
8
0.
45
8
0.
45
8
0.
45
8
0.
45
8
0.
47
5
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Si
nt
er
 p
la
nt
, f
or
em
an
0.
13
8
0.
13
8
0.
13
8
0.
13
8
0.
13
8
0.
15
5
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 b
ra
ke
m
an
0.
09
7
0.
09
7
0.
09
7
0.
09
7
0.
09
7
0.
11
4
0.
11
4
0.
12
1
0.
00
0
 
 
 
 
M
ai
nt
en
an
ce
, d
us
t c
ol
le
ct
or
0.
28
8
0.
28
8
0.
28
8
0.
28
8
0.
28
1
0.
18
1
0.
18
1
0.
14
2
0.
03
2
 
 
 
 
Y
ar
d,
 tr
uc
k/
m
ac
hi
ne
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
01
3
0.
01
3
0.
01
0
0.
00
7
A
m
bi
en
t
 
 
 
 
M
ai
nt
en
an
ce
 sh
op
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
Neurotoxicology. Author manuscript; available in PMC 2015 August 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Park et al. Page 14
Pe
ri
od
1
3
5
6
8
9
10
11
14
M
id
-y
ea
r
19
74
19
77
19
79
19
82
19
85
19
87
19
88
19
89
19
90
 
 
 
 
Si
lic
on
 p
la
nt
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
G
en
er
al
 e
qu
ip
. m
ai
nt
., 
he
ad
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
M
ai
nt
en
an
ce
, s
up
vr
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
D
er
iv
ed
 fr
om
 e
sti
m
at
es
 o
f r
es
pi
ra
bl
e 
M
n 
(ar
ith
me
tic
 m
ea
ns
) (
B
al
dw
in
 e
t a
l.,
 2
00
8).
 D
isp
lay
ed
 fo
r 9
 of
 14
 tim
e p
eri
od
s t
ha
t in
clu
de
d P
eri
od
s 2
 (J
an
. 1
97
6–
Ju
ne
 19
76
) a
nd
 4 
(Ja
n. 
19
78
–J
un
e 1
97
9) 
wh
en
 th
e 
pl
an
t w
as
 c
lo
se
d.
Neurotoxicology. Author manuscript; available in PMC 2015 August 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Park et al. Page 15
Ta
bl
e 
3
Es
tim
at
ed
 sm
al
l r
es
pi
ra
bl
e 
pa
rti
cu
la
te
 e
xp
os
ur
e:
 m
g/
m
3  
as
 r
es
pi
ra
bl
e 
M
n 
(M
n-S
RP
) i
n s
ele
cte
d t
im
e p
eri
od
s.
Pe
ri
od
1
3
5
6
8
9
10
11
14
M
id
-y
ea
r
19
74
19
77
19
79
19
82
19
85
19
87
19
88
19
89
19
90
Pr
im
ar
ily
 fu
m
e
 
 
 
 
Fu
rn
ac
e 
te
am
0.
16
5
0.
16
5
0.
08
2
0.
16
5
0.
52
8
0.
11
8
0.
11
8
0.
07
9
0.
03
5
 
 
 
 
Fu
rn
ac
e,
 la
bo
re
r
0.
39
5
0.
39
5
0.
39
5
0.
39
5
0.
38
7
0.
25
0
0.
25
0
0.
19
5
0.
05
7
 
 
 
 
Fu
rn
ac
e 
lo
ad
er
 o
pr
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
03
0
0.
02
3
0.
01
7
 
 
 
 
Fu
rn
ac
e,
 sa
m
pl
er
0.
13
5
0.
13
5
0.
13
5
0.
13
5
0.
13
5
0.
11
8
0.
11
8
0.
07
9
0.
03
5
 
 
 
 
In
st
ru
m
en
t. 
te
ch
0.
00
8
0.
00
8
0.
00
8
0.
00
8
0.
00
8
0.
00
8
0.
00
8
0.
00
8
0.
00
8
 
 
 
 
Fu
rn
ac
e,
 g
as
 sy
ste
m
0.
16
5
0.
16
5
0.
08
2
0.
16
5
0.
16
5
0.
11
8
0.
11
8
0.
07
9
0.
03
5
 
 
 
 
Fu
rn
ac
e,
 K
re
ss
 o
pr
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
03
0
0.
02
3
0.
01
7
D
us
t a
nd
 fu
m
e
 
 
 
 
Co
nt
ro
l r
m
 o
pr
0.
01
1
0.
01
1
0.
00
6
0.
01
1
0.
03
7
0.
00
8
0.
00
8
0.
00
6
0.
00
3
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 o
th
er
0.
08
7
0.
08
7
0.
08
2
0.
08
7
0.
05
5
0.
05
5
0.
05
5
0.
05
5
0.
02
3
 
 
 
 
El
ec
tri
ci
an
s
0.
16
5
0.
16
5
0.
08
2
0.
16
5
0.
27
6
0.
11
8
0.
11
8
0.
07
9
0.
03
5
 
 
 
 
W
el
de
rs
0.
08
6
0.
08
6
0.
08
2
0.
08
6
0.
08
6
0.
08
6
0.
04
0
0.
02
6
0.
01
2
 
 
 
 
Fi
tte
rs
0.
16
5
0.
16
5
0.
08
2
0.
16
5
0.
21
7
0.
11
8
0.
10
5
0.
07
0
0.
03
1
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 h
op
pe
r
0.
16
5
0.
16
5
0.
08
2
0.
16
5
0.
16
7
0.
11
8
0.
11
8
0.
07
9
0.
00
0
Pr
im
ar
ily
 d
us
t
 
 
 
 
Eq
ui
p 
op
r, 
ra
w
 m
at
l
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
01
0
0.
00
3
0.
00
3
0.
00
3
 
 
 
 
Y
ar
d 
la
bo
re
r
0.
03
1
0.
03
1
0.
03
1
0.
03
1
0.
03
1
0.
03
0
0.
00
4
0.
00
4
0.
00
4
 
 
 
 
Ja
ni
to
r
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
0.
01
5
 
 
 
 
Si
nt
er
 p
la
nt
, o
pr
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
03
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Si
nt
er
 p
la
nt
, l
ab
or
er
, a
ss
t o
pr
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Si
nt
er
 p
la
nt
, f
or
em
an
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
Pr
od
uc
t c
ru
sh
in
g,
 b
ra
ke
m
an
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
03
0
0.
02
3
0.
00
0
 
 
 
 
M
ai
nt
en
an
ce
, d
us
t c
ol
le
ct
or
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
04
7
0.
03
0
0.
03
0
0.
02
3
0.
01
7
 
 
 
 
Y
ar
d,
 tr
uc
k/
m
ac
hi
ne
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
01
3
0.
01
3
0.
01
0
0.
00
7
A
m
bi
en
t
 
 
 
 
M
ai
nt
en
an
ce
 sh
op
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
Neurotoxicology. Author manuscript; available in PMC 2015 August 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Park et al. Page 16
Pe
ri
od
1
3
5
6
8
9
10
11
14
M
id
-y
ea
r
19
74
19
77
19
79
19
82
19
85
19
87
19
88
19
89
19
90
 
 
 
 
Si
lic
on
 p
la
nt
0.
00
1
0.
00
1
0.
00
1
0.
00
1
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
 
 
 
 
G
en
er
al
 e
qu
ip
. m
ai
nt
., 
he
ad
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
 
 
 
 
M
ai
nt
en
an
ce
, s
up
vr
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
0.
02
0
D
er
iv
ed
 fr
om
 e
sti
m
at
es
 o
f r
es
pi
ra
bl
e 
M
n 
(ar
ith
me
tic
 m
ea
ns
) (
B
al
dw
in
 e
t a
l.,
 2
00
8).
 D
isp
lay
ed
 fo
r 9
 of
 14
 tim
e p
eri
od
s t
ha
t in
clu
de
d P
eri
od
s 2
(Ja
n. 
19
76
–J
un
e 1
97
6) 
an
d 4
 (J
an
. 1
97
8–
Ju
ne
 19
79
) w
he
n t
he
 
pl
an
t w
as
 c
lo
se
d.
Neurotoxicology. Author manuscript; available in PMC 2015 August 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Park et al. Page 17
Table 4
Blood manganese (B-Mn) models with Mn duration and Mn respirable particulate cumulative exposures.
Exposure metric R2 t p
None 0.0253 –
Ever exposed (0.1) 0.2032 7.14 <10−10
Duration of exposure, yr 0.1956 6.95 <10−10
Cumulative exposure: total respirable Mn (Mn-TRP) 0.1345 5.37 8 × 10−8
Cumulative exposure: large particulate respirable Mn (Mn-LRP) 0.0885 3.98 7 × 10−5
Cumulative exposure: small particulate respirable Mn (Mn-SRP) 0.1516 5.83 6 × 10−9
With exclusions for missing data on B-Mn, education or age, n: 104 Mn-alloy production workers, 131 non-exposed workers. Model: B-Mn = α + 
β(education-12) + γ(education-12)2+ δ(age-40) + ε(age-40)2 +η(metX), where metX is an exposure metric: duration, cumX, etc.
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Table 6
Models of blood manganese levels with competing Mn metrics using a half-life of 65 days for Mn duration 
and exposure contributions.
Model Estimate t p
1 Intercept (R2 = 0.0253) 0.880 26.30 <0.0001
Age-40 0.006 0.97 0.33
(Age-40)2 −4 × 10−4 −0.92 0.36
Education beyond 12 yr −0.023 −1.78 0.08
(Education beyond 12 yr)2 −0.001 −0.38 0.70
2 Intercept (R2 = 0.2148) 0.723 19.65 <0.0001
Age-40 −0.001 −0.25 0.81
(Age-40)2 3.4 × 10−5 0.08 0.934
Education beyond 12 yr −0.0170 −1.43 0.15
(Education beyond 12 yr)2 8.2 × 10−4 0.33 0.74
Duration 1.34 7.42 <0.0001
3 Intercept (R2 = 0.2162) 0.761 22.36 <0.0001
Age-40 0.001 0.09 0.93
(Age-40)2 9 × 10−4 0.19 0.85
Education beyond 12 yr −0.015 −1.28 0.20
(Education beyond 12 yr)2 −0.001 −0.54 0.59
Small resp. particulate (Mn-SRP) 47.25 7.45 <0.0001
4 Intercept (R2 = 0.2163) 0.761 22.28 <0.0001
Age-40 0.001 0.11 0.91
(Age-40)2 8 × 10−5 0.19 0.85
Education beyond 12 yr −0.015 −1.28 0.20
(Education beyond 12 yr)2 −0.001 −0.56 0.58
Large resp. particulate (Mn-LRP) −1.410 −0.16 0.87
Small resp. particulate (Mn-SRP) 47.87 6.45 <0.0001
5 Intercept (R2 = 0.2363) 0.727 19.98 <0.0001
Age-40 −0.001 −0.20 0.84
(Age-40)2 1 × 10−4 0.26 0.79
Education beyond 12 yr −0.015 −1.30 0.20
(Education beyond 12 yr)2 −2 × 10−4 −0.07 0.94
Duration 0.732 2.45 0.02
Small resp. particulate (Mn-SRP) 26.58 2.53 0.01
6 Intercept (R2 = 0.2334) 0.731 20.75 <0.0001
Age-40 −0.001 −0.18 0.86
(Age-40)2 2 × 10−4 0.37 0.71
Education beyond 12 yr −0.015 −1.28 0.20
(Education beyond 12 yr)2 −3 × 10−4 −0.11 0.91
Mn-SRP (cum. sq. root) 9.147 7.87 <0.0001
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Model Estimate t p
7 Intercept (R2 = 0.2334) 0.731 20.68 <0.0001
Age-40 −0.001 −0.19 0.85
(Age-40)2 2 × 10−4 0.37 0.71
Education beyond 12 yr −0.015 −1.27 0.20
(Education beyond 12 yr)2 −2 × 10−4 −0.10 0.92
Mn-LRP (cum. sq. root) 0.099 0.06 0.95
Mn-SRP (cum. sq. root) 9.102 6.50 <0.0001
8 Intercept (R2= 0.2355) 0.724 19.90 <0.0001
Age-40 −0.001 −0.24 0.81
(Age-40)2 2 × 10−4 0.34 0.73
Education beyond 12 yr −0.015 −1.30 0.20
(Education beyond 12 yr)2 4 × 10−5 0.02 0.99
Duration 0.347 0.79 0.43
Mn-SRP (cum. sq. root) 7.078 2.47 0.01
Blood Mn, B-Mn, as µg/dL; p-value: two-tailed.
Model: B-Mn = α + β(education-12)+ γ(education-12)2 + δ(age-40) + ε(age-12)2 + η(metX1) + υ(metX2), where metXi is an exposure metric: 
duration, Mn-SRP, etc.
Cumulative metrics for Mn-TRP, Mn-LRP and Mn-SRP in mg/m3-yr and duration in yr (with 65 day half-life applied).
With exclusions for missing data on B-Mn, education, age or work history, n: 103 Mn-alloy production workers, 131 non-exposed workers.
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